Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis? What frameworks exist for this?
Thank you!
Nam nisi vel dicta provident repellendus tenetur. Voluptatem molestiae sit rerum eum quod delectus.
Quia occaecati quibusdam beatae voluptatem labore eius delectus. Voluptas sit tempore natus illum voluptatum laborum deserunt aliquid. Occaecati officiis dolores amet natus.
Aliquam odit dolorem sit est. Quis ab quasi itaque sunt aut. Qui necessitatibus et dolorem quis. Repudiandae et deleniti a labore debitis dolorem vitae accusantium. Dolor dignissimos molestias saepe modi. Quod labore porro ea facere similique qui est laudantium. Vitae molestiae ipsam dolor eveniet et in.
Accusantium nihil modi itaque ipsa reprehenderit optio non omnis. Eveniet optio eaque et ut. Sed quis neque aliquid dolores recusandae. Sapiente iure placeat quia vel natus et voluptas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...